Showing results (171-180 of 247) with videos related to

Sort By:
Pageof 25
Intensive Care Medicine|June 20, 2015
Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study, Simon Finfer, Dean Chittock, et al.
Palliative Medicine|February 4, 2015
Admission of the very elderly to the intensive care unit: family members' perspectives on clinical decision-making from a multicenter cohort studyDaren K Heyland, Peter Dodek, Sangeeta Mehta, et al.
The New England Journal of Medicine|March 23, 2011
Dalteparin versus unfractionated heparin in critically ill patients, Deborah Cook, Maureen Meade, et al.
BMJ Supportive & Palliative Care|November 26, 2016
Narrative medicine and death in the ICU: word clouds as a visual legacyMeredith Vanstone, Feli Toledo, France Clarke, et al.
Plos One|May 2, 2025
Implementation and evaluation of the 3 Wishes Project in safety-net hospitals: Protocol for a hybrid effectiveness-implementation studyThanh H Neville, Anne Walling, Neil S Wenger, et al.
The New England Journal of Medicine|April 8, 2011
Functional disability 5 years after acute respiratory distress syndromeMargaret S Herridge, Catherine M Tansey, Andrea Matté, et al.
Critical Care (London, England)|April 29, 2014
Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter auditFrançois Lauzier, John Muscedere, Eric Deland, et al.
Critical Care Medicine|November 8, 2014
Nonbeneficial treatment Canada: definitions, causes, and potential solutions from the perspective of healthcare practitioners*James Downar, John J You, Sean M Bagshaw, et al.
Critical Care (London, England)|March 5, 2008
Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factorsDeborah Cook, James Douketis, Maureen Meade, et al.
Archives of Internal Medicine|September 10, 2008
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT studyJames Douketis, Deborah Cook, Maureen Meade, et al.
Pageof 25